Literature DB >> 17708753

Self-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study.

E D Louis1, J Benito-León, F Bermejo-Pareja.   

Abstract

There are few data on the co-morbidity of essential tremor (ET) with depression. To assess the associations of ET with self-reported depression and antidepressant medication use. In a population-based study in central Spain, participants were evaluated at baseline (1994-1995) and 3 years later. Self-reported depression and use of antidepressant medications were evaluated at each assessment. In cross-sectional analyses, prevalent ET cases were twice more probably than controls to report depression [103 (43.8%) of 235 cases versus 1137 (26.0%) of 4379 controls; adjusted odds ratio (OR) 2.20, 95% confidence interval (CI) 1.66-2.93, P < 0.001] and three times more probably to be taking antidepressant medications [16 (6.8%) cases versus 113 (2.6%) controls; adjusted OR 3.33, 95% CI 1.91-5.82, P = 0.001]. In prospective analyses, baseline self-reported depression (adjusted RR 1.78, 95% CI 1.11-2.89, P = 0.018) and, perhaps, baseline use of antidepressant medication (adjusted RR 1.90, 95% CI 0.59-6.05, P = 0.28) were associated with incident ET. Rather than being totally benign, ET seems to be associated with a mood disorder. Furthermore, as well as being a secondary response to disease manifestations, this mood disorder may be a primary feature of the underlying disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17708753     DOI: 10.1111/j.1468-1331.2007.01923.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  65 in total

1.  Cognition in non-demented Parkinson's disease vs essential tremor: A population-based study.

Authors:  Á Sánchez-Ferro; J Benito-León; E D Louis; I Contador; J Hernández-Gallego; V Puertas-Martín; F Bermejo-Pareja
Journal:  Acta Neurol Scand       Date:  2017-03-05       Impact factor: 3.209

Review 2.  Non-motor symptoms in essential tremor: A review of the current data and state of the field.

Authors:  Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2015-08-29       Impact factor: 4.891

Review 3.  Review on clinical update of essential tremor.

Authors:  Wei Chunling; Xiao Zheng
Journal:  Neurol Sci       Date:  2016-01-09       Impact factor: 3.307

4.  Prehension Kinematics, Grasping Forces, and Independent Finger Control in Mildly Affected Patients with Essential Tremor.

Authors:  Kasja Solbach; Mareike Mumm; Barbara Brandauer; Martin Kronenbürger; Joachim Hermsdörfer; Dagmar Timmann
Journal:  Cerebellum       Date:  2016-08       Impact factor: 3.847

5.  Frailty in elderly persons with essential tremor: a population-based study (NEDICES).

Authors:  E D Louis; J Benito-León; S Vega; F Bermejo-Pareja
Journal:  Eur J Neurol       Date:  2011-03-22       Impact factor: 6.089

6.  Essential tremor: is it a neurodegenerative disease? No.

Authors:  Monica M Kurtis
Journal:  J Neural Transm (Vienna)       Date:  2012-08-17       Impact factor: 3.575

7.  Low morale is associated with increased risk of mortality in the elderly: a population-based prospective study (NEDICES).

Authors:  Julián Benito-León; Elan D Louis; Jesús Rivera-Navarro; María José Medrano; Saturio Vega; Félix Bermejo-Pareja
Journal:  Age Ageing       Date:  2010-03-17       Impact factor: 10.668

8.  Essential tremor: one of the most common neurodegenerative diseases?

Authors:  Julián Benito-León
Journal:  Neuroepidemiology       Date:  2011-01-19       Impact factor: 3.282

Review 9.  From neurons to neuron neighborhoods: the rewiring of the cerebellar cortex in essential tremor.

Authors:  Elan D Louis
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

10.  Cognitive decline in short and long sleepers: a prospective population-based study (NEDICES).

Authors:  Julián Benito-León; Elan D Louis; Félix Bermejo-Pareja
Journal:  J Psychiatr Res       Date:  2013-09-20       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.